C Batman1, O Cekiç. 1. SSK Ankara Eye Hospital, Department of Vitreoretinal Surgery, Turkey.
Abstract
PURPOSE: To determine if either silicone oil or perfluoropropane (C3F8) gas is superior to the other in the treatment of giant retinal tears complicated by proliferative vitreoretinopathy. METHODS:Forty-seven eyes with giant retinal tears were treated in a prospective randomized fashion. Twenty-two eyes were randomized to C3F8 gas and 25 eyes were randomized to silicone oil. Follow-up of 60 months is reported. Of the silicone oil-treated eyes, 9 had oil retained in the eye; oil was removed from the remaining 16 eyes. Successful anatomic attachment of the retina, final visual acuity, and surgical complications were the main outcome measures. RESULTS: There were no differences between the groups in any of the main outcome measures. CONCLUSIONS: This study showed that silicone oil and C3F8 gas are equal in most respects for the management of giant retinal tears with proliferative vitreoretinopathy.
RCT Entities:
PURPOSE: To determine if either silicone oil or perfluoropropane (C3F8) gas is superior to the other in the treatment of giant retinal tears complicated by proliferative vitreoretinopathy. METHODS: Forty-seven eyes with giant retinal tears were treated in a prospective randomized fashion. Twenty-two eyes were randomized to C3F8 gas and 25 eyes were randomized to silicone oil. Follow-up of 60 months is reported. Of the silicone oil-treated eyes, 9 had oil retained in the eye; oil was removed from the remaining 16 eyes. Successful anatomic attachment of the retina, final visual acuity, and surgical complications were the main outcome measures. RESULTS: There were no differences between the groups in any of the main outcome measures. CONCLUSIONS: This study showed that silicone oil and C3F8 gas are equal in most respects for the management of giant retinal tears with proliferative vitreoretinopathy.
Authors: M Sirimaharaj; C Balachandran; W C Chan; A P Hunyor; A A Chang; J Gregory-Roberts; A B Hunyor; T J Playfair Journal: Br J Ophthalmol Date: 2005-09 Impact factor: 4.638
Authors: John C Randolph; Rocio I Diaz; Eric J Sigler; Jorge I Calzada; Steve Charles Journal: Graefes Arch Clin Exp Ophthalmol Date: 2015-05-12 Impact factor: 3.117
Authors: Katie X Li; Nicholas Carducci; Omar Moinuddin; Yunshu Zhou; David C Musch; David N Zacks; Cagri G Besirli; Thomas J Wubben Journal: Clin Ophthalmol Date: 2021-03-08
Authors: Mario Gutierrez; Jose L Rodriguez; Diego Zamora-de La Cruz; Mariana Aracely Flores Pimentel; Aida Jimenez-Corona; Linda C Novak; Rene Cano Hidalgo; Federico Graue Journal: Cochrane Database Syst Rev Date: 2019-12-16
Authors: Marianeli Rodriguez; James Lin; Justin H Townsend; William E Smiddy; Thomas A Albini; Audina M Berrocal; Jayanth Sridhar; Harry W Flynn Journal: Clin Ophthalmol Date: 2018-10-12